Description

The full spectrum of pediatric emergency transfusion includes transfusion that occur before arrival to the hospital as well as events that occur at arrival or during hospitalization. In this session, the speakers will address the outcome of pediatric patients experiencing acute blood loss in these various settings. Speakers will describe the demographics and blood usage of pediatric patients that require transfusion during emergency transport to the hospital and after arrival. Best practices in a pediatric massive transfusion protocol for the hospitalized patient will be reviewed with an emphasis on how to optimize the process. The blood product selection for massive transfusion in pediatrics patients will highlight the rationale and current data on the experience with Low Titer Group O Whole Blood in pediatric patients.

Learning Objectives:

• Explain the demographics, transfusion practices and outcomes of pediatric patients who receive pre-hospital transfusion with RBCs and plasma.
• Formulate the critical components of a massive transfusion protocol for pediatric patients to include antifibrinolytics and coagulation factor concentrates.
• Evaluate the evidence describing the use of whole blood to resuscitate pediatric patients requiring emergency transfusion in the prehospital or in hospital phase of resuscitation.

Speaker(s):

• Dr. Cyril Jacquot, MD PhD, Children's National Medical Center
• Cassandra D. Josephson, MD, Emory University School of Medicine
• Dr. Philip C. Spinella, MD, FCCM, Washington University School of Medicine

Disclosures

• Cyril Jacquot, MD PhD : Nothing to disclose
• Cassandra Josephson, MD : Consultant: Immucor, Octapharma, Biomet Zimmer; Grant/Research Support: Medtronics, Sysmex
• Philip Spinella, MD, FCCM : Consultant: Hemantext, Secure Transfusion Services